Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Genetic tug of war in the brain influences parental control over offspring behavior

  • Experts recommend tumor removal as first-line treatment for Cushing's syndrome

  • Discovery about brain protein causes rethink on development of Alzheimer's disease

  • Brain-controlled prosthesis nearly as good as one-finger typing

  • New structural features of human hair discovered

  • Depressed females have over-active glutamate receptor gene

  • The body and the brain: Impact of mental, physical exertion on fatigue development

  • Trying to quit smoking? First strengthen self-control

  • Take a Trip Through the Brain: New Imaging Tool

  • Blood test predicts prognosis for traumatic brain injuries

  •